Clinical Trials Logo

Clinical Trial Summary

The main objective of this study is to demonstrate that 15 transcranial direct current stimulation (tDCS) sessions of 30 minutes at 2 mA intensity are effective to reduce suicidal ideation


Clinical Trial Description

After being informed about the study and potential risks, all patients giving written informed consent will undergo a screening visit to determine eligibility for study entry. Patient who meet the eligibility requirements be able to start the 15 tDCS sessions at the rate of one session per day. After the last session, patients will perform three follow-up visits on D19, D49 and D79 ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06009523
Study type Interventional
Source Centre Hospitalier Henri Laborit
Contact Ghina Harika-Germaneau
Phone 05.16.52.61.18
Email ghina.harika-germaneau@ch-poitiers.fr
Status Recruiting
Phase N/A
Start date October 26, 2023
Completion date December 1, 2026

See also
  Status Clinical Trial Phase
Completed NCT02566980 - Biological Triggers of Depression in Pregnancy
Completed NCT04266288 - Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department Phase 4
Recruiting NCT05437588 - Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents N/A
Recruiting NCT04760652 - Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention N/A
Active, not recruiting NCT05930912 - Psychiatric Orders in Psychoanalytic Treatment of ASD
Completed NCT03601117 - Accelerated Intermittent Theta Burst Stimulation for Depressive Symptoms N/A
Recruiting NCT04572321 - Youth Depression and Suicide Research Network